ACIP Recommendations: Hepatitis A Vaccine

Published in Morbidity and Mortality Report (MMWR)

The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).

CURRENT Hepatitis A Vaccine Recommendations

• MMWR, July 3, Vol 69(5);1–38
  Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020
  Print version
• See also:
  • ACIP VFC Resolution

ARCHIVED Hepatitis A Immunization Publications

For your convenience, these archived publications can be used for historical and research purposes.

• MMWR, February 15, Vol 68(6);153–156
  Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing Homelessness
  Print version
• MMWR, November 2, 2018, Vol 67(43);1216–1220
  Updated Recommendations from the ACIP for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel
  Print version
• MMWR, September 18, 2009, Vol 58(36);1006-1007
  Updated Recommendations from the ACIP for Use of Hepatitis A Vaccine in Close Contacts of Newly Arriving International Adoptees
  Print version
• MMWR, October 12, 2007, Vol 56(40);1057
  Notice to Readers: FDA Approval of an Alternate Dosing Schedule for a Combined Hepatitis A and B Vaccine (Twinrix^®)
  Print version
• MMWR, October 19, 2007, Vol 56(41);1080-1084
  Update: Prevention of Hepatitis A After Exposure to Hepatitis A Virus and in International Travelers. Updated Recommendations of the ACIP
  Print version
• MMWR, May 19, 2006, Vol 55(RR-07);1-23
  Prevention of Hepatitis A Through Active or Passive Immunization
  Print version
• MMWR, December 9, 2005, Vol 54(48);1235-1236
  Notice to Readers: FDA Approval of Havrix® (Hepatitis A Vaccine, Inactivated) for Persons Aged 1-18 Years
  Print version
• MMWR, October 14, 2005, Vol 54(40);1026
  Notice To Readers: FDA Approval of VAQTA® (Hepatitis A Vaccine, Inactivated) for Children Aged >1 Year
  Print version
• MMWR, September 21, 2001, Vol 50(37);806-7
  Notice to Readers: FDA Approval for a Combined Hepatitis A and B Vaccine
  Print version